- Home
- TRUE vs MOLN Comparison
TRUE vs MOLN Comparison
Compare TRUE & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- MOLN
- Stock Information
- Founded
- TRUE 2005
- MOLN 2004
- Country
- TRUE United States
- MOLN Switzerland
- Employees
- TRUE N/A
- MOLN N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- MOLN
- Sector
- TRUE Technology
- MOLN
- Exchange
- TRUE Nasdaq
- MOLN Nasdaq
- Market Cap
- TRUE 171.0M
- MOLN 142.6M
- IPO Year
- TRUE 2014
- MOLN 2021
- Fundamental
- Price
- TRUE $2.27
- MOLN $3.64
- Analyst Decision
- TRUE Buy
- MOLN Hold
- Analyst Count
- TRUE 5
- MOLN 1
- Target Price
- TRUE $3.19
- MOLN $4.00
- AVG Volume (30 Days)
- TRUE 413.3K
- MOLN 5.1K
- Earning Date
- TRUE 11-05-2025
- MOLN 11-05-2025
- Dividend Yield
- TRUE N/A
- MOLN N/A
- EPS Growth
- TRUE N/A
- MOLN N/A
- EPS
- TRUE N/A
- MOLN N/A
- Revenue
- TRUE $184,559,000.00
- MOLN $856,302.00
- Revenue This Year
- TRUE $8.42
- MOLN N/A
- Revenue Next Year
- TRUE $5.64
- MOLN $1,000.00
- P/E Ratio
- TRUE N/A
- MOLN N/A
- Revenue Growth
- TRUE 11.66
- MOLN N/A
- 52 Week Low
- TRUE $1.05
- MOLN $3.36
- 52 Week High
- TRUE $4.62
- MOLN $7.60
- Technical
- Relative Strength Index (RSI)
- TRUE 55.33
- MOLN 48.04
- Support Level
- TRUE $1.91
- MOLN $3.69
- Resistance Level
- TRUE $2.53
- MOLN $3.79
- Average True Range (ATR)
- TRUE 0.17
- MOLN 0.11
- MACD
- TRUE 0.01
- MOLN -0.00
- Stochastic Oscillator
- TRUE 52.00
- MOLN 27.03
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.